Clinical Trial Update: A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment [Phase 1, Phase 2]

View source ↗

Summary

A Clinical Trial Update indicates RM-718 is being studied in Phase 1/Phase 2 in healthy subjects and patients with MC4R pathway impairment, including hypothalam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity
• Prader-willi Syndrome

Drugs mentioned

• RM-718

Snippet

Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Hypothalamic Obesity, Prader-Willi Syndrome | Phase 1, Phase 2 | Status: RECRUITING